Latest Insider Transactions at Revance Therapeutics, Inc. (RVNC)
This section provides a real-time view of insider transactions for Revance Therapeutics, Inc. (RVNC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Revance Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Revance Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2020
|
Mark J Foley President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
143,269
-20.05%
|
$3,581,725
$25.14 P/Share
|
|
Sep 30
2020
|
Mark J Foley President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
301,000
+29.64%
|
-
|
|
Sep 30
2020
|
Dustin S Sjuts President |
SELL
Payment of exercise price or tax liability
|
Direct |
6,051
-11.73%
|
$151,275
$25.14 P/Share
|
|
Sep 30
2020
|
Dustin S Sjuts President |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+25.34%
|
-
|
|
Sep 28
2020
|
Aubrey Rankin Director |
SELL
Open market or private sale
|
Indirect |
33,119
-5.43%
|
$861,094
$26.18 P/Share
|
|
Jul 23
2020
|
Mark J Foley President & CEO |
BUY
Grant, award, or other acquisition
|
Indirect |
50,913
+41.79%
|
-
|
|
Jul 23
2020
|
Mark J Foley President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
264,439
+24.04%
|
-
|